The status of KRAS mutations in primary ovarian clear cell carcinoma: An analysis of 17 Taiwanese patients

Taiwan J Obstet Gynecol. 2023 Mar;62(2):384-386. doi: 10.1016/j.tjog.2023.01.004.
No abstract available

Publication types

  • Letter

MeSH terms

  • Carcinoma*
  • Female
  • Humans
  • Mutation
  • Ovarian Neoplasms* / genetics
  • Proto-Oncogene Proteins p21(ras) / genetics

Substances

  • Proto-Oncogene Proteins p21(ras)
  • KRAS protein, human